28 Results for "

Remdesivir

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "Remdesivir" in MCE Product Catalog:

226
226 Publications Verification
Cat. No.: HY-104077
CAS No.: 1809249-37-3
Purity:  99.95%
Synonyms: GS-5734
Research Areas:  

Infection

Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection .
loading...
    loading...
46
46 Cited Publications
Cat. No.: HY-10241
CAS No.: 923604-59-5
Purity:  98.79%
Synonyms: TMC435; TMC435350
Research Areas:  

Infection

Simeprevir (TMC435; TMC435350) is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir inhibits the main protease (M pro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-126303C
CAS No.: 1355050-21-3
Purity:  99.98%
Synonyms: GS-441524 triphosphate trisodium; Remdesivir metabolite trisodium
Research Areas:  

Infection

GS-443902 trisodium (GS-441524 triphosphate trisodium) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 1.1 μM, 5 μM for RSV RdRp and HCV RdRp, respectively. GS-443902 trisodium is the active triphosphate metabolite of Remdesivir (GS-5734) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-136303
CAS No.: 1911579-04-8
Purity:  99.63%
Target:  

Drug Metabolite

Research Areas:  

Infection

GS-704277 is an alanine metabolite of Remdesivir (HY-104077). GS-704277 is further hydrolyzed to GA-441524 (HY-103586) with antiviral activity. Remdesivir, a nucleoside analogue with effective antiviral activity, is highly effective in the control of SARS-CoV-2 (COVID-19) infection .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-44358
CAS No.: 1911578-74-9
Research Areas:  

Infection

Remdesivir nucleoside monophosphate is a metabolite of Remdesivir (HY-104077) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-136597
CAS No.: 1191237-80-5
Purity:  99.83%
Research Areas:  

Infection

Remdesivir O-desphosphate acetonide impurity is an impurity of Remdesivir. Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity and is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-104077S
Purity:  99.86%
Synonyms: GS-5734-d5
Remdesivir-d5 (GS-5734-d5) is a deuterium labeled Remdesivir (HY-104077). Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection .
loading...
    loading...
Cat. No.: HY-145119AS
CAS No.: 2779498-79-0
Purity:  99.46%
Synonyms: VV116; GS-621763-d1 hydrobromide
Mindeudesivir (JT001; VV116; GS-621763-d1) hydrobromide is a deuterated version of Remdesivir (HY-104077), a highly orally active nucleoside antiviral against SARS-CoV-2 and respiratory syncytial virus (RSV). Mindeudesivir hydrobromide retains the antiviral activity of Remdesivir against COVID-19, and is the first domestically produced deuterium targeting the COVID-19 .
loading...
    loading...
Cat. No.: HY-133894
CAS No.: 2103278-86-8
Purity:  ≥96.0%
Synonyms: FB2001
Target:  

SARS-CoV

Research Areas:  

Infection

Bofutrelvir (FB2001) is a SARS-CoV-2 main protease M pro inhibitor with an IC50 value of 53 nM and an EC50 value of 0.53 μM. Bofutrelvir exhibits potent antiviral efficacy against several current SARS-CoV-2 variants with EC50 values of 0.26-0.42 μM. Bofutrelvir has an additive antiviral effect when combined with Remdesivir (HY-104077) .
loading...
    loading...
Cat. No.: HY-104077S1
Synonyms: GS-5734-d4
Remdesivir-d4 (GS-5734-d4) is deuterium labeled Remdesivir (HY-104077). Remdesivir (GS-5734) is a nucleoside analogue with effective antiviral activity. Remdesivir can inhibit the synthesis of viral DNA or RNA. Remdesivir can be used for the research of infection, such as SARS-CoV and MHV infection .
loading...
    loading...
Cat. No.: HY-126303
CAS No.: 1355149-45-9
Synonyms: GS-441524 triphosphate; Remdesivir metabolite
Research Areas:  

Infection

GS-443902 (GS-441524 triphosphate) is a potent viral RNA-dependent RNA-polymerases (RdRp) inhibitor with IC50s of 1.1 µM, 5 µM for RSV RdRp and HCV RdRp, respectively. GS-443902 is the active triphosphate metabolite of Remdesivir .
loading...
    loading...
Cat. No.: HY-131233
CAS No.: 1911578-83-0
Purity:  99.01%
Synonyms: Remdesivir isopropyl ester analog
Target:  

Antibiotic

Research Areas:  

Infection

Anti-virus agent 1 (compound 4i), a phosphoramidate proagent of GS-5734 (HY-104077; Remdesivir), has potent antiviral activity. Anti-virus agent 1 is used for the research of coronavirus and Ebola virus (EBOV) .
loading...
    loading...
Cat. No.: HY-104077R
CAS No.: 1809249-37-3
Synonyms: GS-5734 (Standard)
Research Areas:  

Infection

Remdesivir (Standard) (GS-5734 (Standard)) is a nucleoside analogue with effective antiviral activity. Remdesivir (Standard) can inhibit the synthesis of viral DNA or RNA. Remdesivir (Standard) can be used for the research of infection, such as SARS-CoV and MHV infection .
loading...
    loading...
Cat. No.: HY-161356
CAS No.: 1345406-09-8
Research Areas:  

Infection

BPR3P0128 is an orally active, non-nucleoside RNA-dependent RNA polymerase (RdRp) inhibitor that has been shown to inhibit the activity of various SARS-CoV-2 variants. The EC50 for SARS-CoV-2 and HCoV-229E are 0.62 μM and 0.14 μM. BPR3P0128 demonstrates effective anti-pancoronavirus activity within the submicromolar range. PR3P0128 shows synergistic antiviral activity when combined with Remdesivir (HY-104077) .
loading...
    loading...
Cat. No.: HY-W076298
CAS No.: 1354823-36-1
Target:  

SARS-CoV

Research Areas:  

Infection

Remdesivir intermediate-1 is a synthetic intermediate that can be used in the synthesis of Remdesivir (HY-104077).
loading...
    loading...
Cat. No.: HY-145949
CAS No.: 2607871-93-0
Target:  

Drug Metabolite

Research Areas:  

Infection

Remdesivir de(ethylbutyl 2-aminopropanoate) is an impurity of Remdesivir. Remdesivir, a nucleoside analogue with effective antiviral activity, has EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro .
loading...
    loading...
Cat. No.: HY-136597R
CAS No.: 1191237-80-5
Research Areas:  

Infection

Remdesivir O-desphosphate acetonide impurity (Standard) is the analytical standard of Remdesivir O-desphosphate acetonide impurity. This product is intended for research and analytical applications.
loading...
    loading...
Cat. No.: HY-150679S
Synonyms: GS-5734-13C6
Remdesivir- 13C6 is the 13C labeled Remdesivir .
loading...
    loading...
Cat. No.: HY-10241A
CAS No.: 1241946-89-3
Synonyms: TMC435 sodium; TMC435350 sodium
Research Areas:  

Infection

Simeprevir (TMC435; TMC435350) sodium is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir sodium inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir sodium also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir sodium inhibits the main protease (M pro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses .
loading...
    loading...
Cat. No.: HY-10241S
Synonyms: TMC435-13C,d3; TMC435350-13C,d3
Simeprevir- 13C,d3 is the 13C- and deuterium labeled Simeprevir. Simeprevir is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses .
loading...
    loading...